This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oksi, J. Articles by Viljanen, M. K. Search for Related Content PubMed PubMed Citation Articles by Oksi, J. Articles by Viljanen, M. K.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, Sep 1995, 2260-2264, Vol 33, No. 9
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Antibodies against whole sonicated Borrelia burgdorferi spirochetes, 41- kilodalton flagellin, and P39 protein in patients with PCR- or culture- proven late Lyme borreliosis

J Oksi, J Uksila, M Marjamaki, J Nikoskelainen and MK Viljanen
Department of Medicine, Turku University Central Hospital, Finland.

The sensitivities and specificities of three enzyme-linked immunosorbent assays (ELISAs) for Borrelia burgdorferi antibodies were compared for 41 patients presenting with symptoms compatible with late Lyme borreliosis (LB) and 37 healthy controls. All subjects were living in southwestern Finland, where LB is endemic. Only patients with culture- or PCR-proven disease were enrolled in the study. The antigens of the ELISAs consisted of sonicated spirochetes, 41-kDa flagellin, and recombinant P39 protein of B. burgdorferi. Fifteen patients had strongly or moderately positive results in the serological assay(s), 19 patients had only weakly positive or borderline antibody levels, and the remaining 7 patients were seronegative by ELISA. The sensitivities of the ELISAs were 78.0% with sonicate antigen, 41.5% with 41-kDa flagellin, and 14.6% with P39 protein. The specificities of the tests were 89.2, 86.5, and 94.6%, respectively. The sonicate antigen ELISA seems to be an effective screening method. These results show that antibodies to B. burgdorferi may be present in low levels or even absent in patients with culture- or PCR-proven late LB. Therefore, in addition to serological testing, the use of PCR and cultivation is recommended in the diagnosis of LB.

This article has been cited by other articles:

• Joss, A W L, Evans, R, Mavin, S, Chatterton, J, Ho-Yen, D O (2008). Development of real time PCR to detect Toxoplasma gondii and Borrelia burgdorferi infections in postal samples. J. Clin. Pathol. 61: 221-224 [Abstract] [Full Text]  
• Mayer, L., Merz, S., Maloney, E. L., Holmes, K. D., Volkman, D. J., Cameron, D. J., Drapkin, M. S., Feder, H. M. Jr., the Ad Hoc International Lyme Disease Group, (2008). An Appraisal of "Chronic Lyme Disease". NEJM 358: 428-431 [Full Text]  
• Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., Wormser, G. P. (2005). Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev. 18: 484-509 [Abstract] [Full Text]  
• Ramamoorthy, R., McClain, N. A., Gautam, A., Scholl-Meeker, D. (2005). Expression of the bmpB Gene of Borrelia burgdorferi Is Modulated by Two Distinct Transcription Termination Events. J. Bacteriol. 187: 2592-2600 [Abstract] [Full Text]  
• Panelius, J., Lahdenne, P., Saxen, H., Heikkila, T., Seppala, I. (2001). Recombinant Flagellin A Proteins from Borrelia burgdorferi Sensu Stricto, B. afzelii, and B. garinii in Serodiagnosis of Lyme Borreliosis. J. Clin. Microbiol. 39: 4013-4019 [Abstract] [Full Text]  
• Kouzmitcheva, G. A., Petrenko, V. A., Smith, G. P. (2001). Identifying Diagnostic Peptides for Lyme Disease through Epitope Discovery. CVI 8: 150-160 [Abstract] [Full Text]  
• Oksi, J, Kalimo, H, Marttila, R J, Marjamaki, M, Sonninen, P, Nikoskelainen, J, Viljanen, M K (1998). Intracranial aneurysms in three patients with disseminated Lyme borreliosis: cause or chance association?. J. Neurol. Neurosurg. Psychiatry 64: 636-642 [Abstract] [Full Text]  
• Tu, J., Yu, Z., Chu, Y.-H. (1998). Combinatorial search for diagnostic agents: Lyme antibody H9724 as an example. Clin. Chem. 44: 232-238 [Abstract] [Full Text]